MERAND PHARMACEUTICALS
Merand Pharmaceuticals develops a microRNA therapeutic to treat Peripheral Arterial Disease. Merand's therapeutic treats patients by promoting angiogenesis or the development of new blood vessels, which leads to restored blood flow, enabling doctors to stabilize functional blood vessels of patients to increase perfusion recovery and reduce inflammation.
MERAND PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Charlottesville, Virginia, United States
Country:
United States
Status:
Active
Total Funding:
0
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investors List
CAV Angels
CAV Angels investment in Seed Round - Merand Pharmaceuticals
Charlottesville Angel Network
Charlottesville Angel Network investment in Seed Round - Merand Pharmaceuticals
UVA Licensing & Ventures Group
UVA Licensing & Ventures Group investment in Seed Round - Merand Pharmaceuticals